The Market and Sector Headlines section monitors pharma and stock across India's pharmaceutical sector. Significant developments around biotech continue to draw attention from regulators, investors, and industry professionals, reflecting the dynamic pace of change in this space.
Recent coverage has drawn from Bez Kabli, The Economic Times, and AD HOC NEWS, among other publications. This section is updated as new stories emerge, ensuring readers have access to the most current information shaping this part of the pharmaceutical landscape.
For authoritative reference, BSE Healthcare Index and NSE Pharma Sector publish official guidance and regulatory documentation relevant to these topics. Peer-reviewed research and clinical data can be accessed through IQVIA Industry Reports.
Showing 30 articles
-
Curanex Stock Sinks Toward 31 Cents as Nasdaq Clock Ticks
Curanex Stock Sinks Toward 31 Cents as Nasdaq Clock Ticks Bez Kabli
-
Why aTyr Pharma Stock Is Sliding Before a Key June FDA Filing
Why aTyr Pharma Stock Is Sliding Before a Key June FDA Filing Bez Kabli
-
Regulator, cos discuss price hike for some cancer drugs
Regulator, cos discuss price hike for some cancer drugs The Economic Times
-
Pfizer Inc. stock (US7170811035): shares steady ahead of next catalyst as investors focus on valuati
Pfizer Inc. stock (US7170811035): shares steady ahead of next catalyst as investors focus on valuati AD HOC NEWS
-
Sartorius Stedim Biotech stock (FR0013154002): shares edge higher while valuation remains demanding
Sartorius Stedim Biotech stock (FR0013154002): shares edge higher while valuation remains demanding AD HOC NEWS
-
Concord Biotech Stock Gains 7% After USFDA Approval For Immunosuppressant Drug
Concord Biotech Stock Gains 7% After USFDA Approval For Immunosuppressant Drug BW Businessworld
-
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs TradingView
-
Parabilis eyes $475m IPO to push lead asset into Phase III
Parabilis eyes $475m IPO to push lead asset into Phase III Pharmaceutical Technology
-
Tecan Group (SWX:TECN) Valuation Check As India Expansion Follows Recent South Korea Move
Tecan Group (SWX:TECN) Valuation Check As India Expansion Follows Recent South Korea Move simplywall.st
-
U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.07% By Investing.com
U.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.07% By Investing.com Investing.com UK
-
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.07% By Investing.com
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.07% By Investing.com Investing.com
-
Norway shares higher at close of trade; Oslo OBX up 0.04% By Investing.com
Norway shares higher at close of trade; Oslo OBX up 0.04% By Investing.com Investing.com India
-
Norway shares higher at close of trade; Oslo OBX up 0.04%
Norway shares higher at close of trade; Oslo OBX up 0.04% Investing.com UK
-
Norway stocks higher at close of trade; Oslo OBX up 0.04%
Norway stocks higher at close of trade; Oslo OBX up 0.04% Investing.com
-
4 Biotech Stocks Investors Should Watch in 2026
4 Biotech Stocks Investors Should Watch in 2026 TradingView
-
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech AOL.com
-
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech The Motley Fool
-
OncoZenge resolves on a directed share issue to Sichuan Yangtian Bio-Pharmaceutical pursuant to existing investment agreement
OncoZenge resolves on a directed share issue to Sichuan Yangtian Bio-Pharmaceutical pursuant to existing investment agreement TradingView
-
Strong physician interest in Annamycin reported by Moleculin (NASDAQ: MBRX)
Strong physician interest in Annamycin reported by Moleculin (NASDAQ: MBRX) Stock Titan
-
Sun Pharmaceutical Industries Ltd is Rated Buy
Sun Pharmaceutical Industries Ltd is Rated Buy Markets Mojo
-
Possible Bearish Signals With Eton Pharmaceuticals Insiders Disposing Stock
Possible Bearish Signals With Eton Pharmaceuticals Insiders Disposing Stock simplywall.st
-
Norges Bank Invests $131.92 Million in Royalty Pharma PLC $RPRX
Norges Bank Invests $131.92 Million in Royalty Pharma PLC $RPRX MarketBeat
-
Bullish block trade of HANSOH PHARMA(03692) 174K shares at $29.12, $5.067M turnover
Bullish block trade of HANSOH PHARMA(03692) 174K shares at $29.12, $5.067M turnover AASTOCKS.com
-
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock.
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock. The Motley Fool
-
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock.
Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock. The Globe and Mail
-
Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79%
Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79% Business Upturn
-
Avecho Biotechnology (ASX: AVE) Moves Higher as Investors Monitor Development Progress
Avecho Biotechnology (ASX: AVE) Moves Higher as Investors Monitor Development Progress Kalkine
-
Market Cap Disconnect: Evidence from Indian Pharma
Market Cap Disconnect: Evidence from Indian Pharma The Financial World
-
CMSI: Three Reasons for Recent Underperformance of Pharma Sector vs HSI; Top Picks INNOVENT BIO (01801.HK), HANSOH PHARMA (03692.HK) and KEYMED BIO-B (02162.HK)
CMSI: Three Reasons for Recent Underperformance of Pharma Sector vs HSI; Top Picks INNOVENT BIO (01801.HK), HANSOH PHARMA (03692.HK) and KEYMED BIO-B (02162.HK) AASTOCKS.com
-
CMSI: 3 Reasons for Recent Underperformance of Pharma Sector vs HSI; Top Picks INNOVENT BIO/ HANSOH PHARMA/ KEYMED BIO-B
CMSI: 3 Reasons for Recent Underperformance of Pharma Sector vs HSI; Top Picks INNOVENT BIO/ HANSOH PHARMA/ KEYMED BIO-B AASTOCKS.com